BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27889055)

  • 1. Medical or surgical management of fibroids? An internet survey of gynecologists' views.
    Pazzaglia E; Praet J; Vandromme J; Rozenberg S
    Maturitas; 2017 Jan; 95():6-10. PubMed ID: 27889055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of uterine leiomyomas.
    Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
    J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMAS position statement: management of uterine fibroids.
    Pérez-López FR; Ornat L; Ceausu I; Depypere H; Erel CT; Lambrinoudaki I; Schenck-Gustafsson K; Simoncini T; Tremollieres F; Rees M;
    Maturitas; 2014 Sep; 79(1):106-16. PubMed ID: 24975954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging treatment options for uterine fibroids.
    Donnez J; Arriagada P; Donnez O; Dolmans MM
    Expert Opin Emerg Drugs; 2018 Mar; 23(1):17-23. PubMed ID: 29486606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice?
    Donnez J; Donnez O; Dolmans MM
    Fertil Steril; 2014 Sep; 102(3):640-8. PubMed ID: 25106762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selective progesterone receptor modulator (ulipristal acetate--a new option in the pharmacological treatment of uterine fibroids in women].
    Szamatowicz M; Kotarski J
    Ginekol Pol; 2013 Mar; 84(3):219-22. PubMed ID: 23700851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ulipristal acetate for use in moderate to severe symptoms of uterine fibroids.
    Talaulikar VS; Manyonda I
    Womens Health (Lond); 2014 Nov; 10(6):565-70. PubMed ID: 25482483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic management of uterine fibroid tumors: updated French guidelines.
    Marret H; Fritel X; Ouldamer L; Bendifallah S; Brun JL; De Jesus I; Derrien J; Giraudet G; Kahn V; Koskas M; Legendre G; Lucot JP; Niro J; Panel P; Pelage JP; Fernandez H;
    Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):156-64. PubMed ID: 22939241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine fibroid management: from the present to the future.
    Donnez J; Dolmans MM
    Hum Reprod Update; 2016 Nov; 22(6):665-686. PubMed ID: 27466209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Choices in a National Cohort of Canadian Women With Symptomatic Uterine Fibroids.
    Strand T; Kives S; Leyland N; Ashkenas J; Janiszewski P; Thiel J
    J Obstet Gynaecol Can; 2020 Dec; 42(12):1475-1482.e2. PubMed ID: 33046429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a gynecologist-interventional radiologist relationship on selection of treatment modality for the patient with uterine myoma.
    Zurawin RK; Fischer JH; Amir L
    J Minim Invasive Gynecol; 2010; 17(2):214-21. PubMed ID: 20226411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulipristal acetate: a novel option for the medical management of symptomatic uterine fibroids.
    Talaulikar VS; Manyonda IT
    Adv Ther; 2012 Aug; 29(8):655-63. PubMed ID: 22903240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ulipristal acetate in the management of symptomatic uterine fibroids: facts and pending issues.
    Pérez-López FR
    Climacteric; 2015 Apr; 18(2):177-81. PubMed ID: 25390187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
    Barlow DH; Lumsden MA; Fauser BC; Terrill P; Bestel E
    Hum Reprod; 2014 Mar; 29(3):480-9. PubMed ID: 24457604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on medical treatment of uterine fibroids.
    Faustino F; Martinho M; Reis J; Águas F
    Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():61-68. PubMed ID: 28732252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of uterine fibroids in women with otherwise unexplained infertility.
    Carranza-Mamane B; Havelock J; Hemmings R; ;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroid management in premenopausal women.
    Donnez J; Courtoy GE; Dolmans MM
    Climacteric; 2019 Feb; 22(1):27-33. PubMed ID: 30601065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Danish gynecologists' opinion about hysterectomy on benign indication: results of a survey.
    Gimbel H; Ottesen B; Tabor A
    Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1123-31. PubMed ID: 12519108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Place of ulipristal acetate in the management of uterine fibroids: Preoperative treatment or sequential treatment?
    Pourcelot AG; Capmas P; Fernandez H
    J Gynecol Obstet Hum Reprod; 2017 Mar; 46(3):249-254. PubMed ID: 28403922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.